The Biotech Growth Trust PLC plan to sell securities of Enliven Therapeutics, Inc. under Form 144

The Biotech Growth Trust PLC filed Form 144 to notify SEC of plan to sell 10243 units of Enliven Therapeutics, Inc. securities around 2026-06-15, with aggregate market value of $433,893.48. The total outstanding units is 69822989.0. The amount planned to be sold represents 0.01% of total outstanding units;